Literature DB >> 33583202

Treatment of Primary Aldosteronism Increases Plasma Epoxyeicosatrienoic Acids.

James M Luther1, Dawei S Wei1, Kakali Ghoshal2, Dungeng Peng1, Gail K Adler3, Adina F Turcu4, Hui Nian5, Chang Yu5, Carmen C Solorzano6, Ambra Pozzi2,7, Nancy J Brown1,8.   

Abstract

[Figure: see text].

Entities:  

Keywords:  aldosterone; eicosanoids; hypertension; insulin resistance; mineralocorticoids

Mesh：

Substances：

Year:  2021        PMID： 33583202      PMCID： PMC8320355          DOI： 10.1161/HYPERTENSIONAHA.120.14808

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


  38 in total

1.  Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.

Authors:  Z Yu; F Xu; L M Huse; C Morisseau; A J Draper; J W Newman; C Parker; L Graham; M M Engler; B D Hammock; D C Zeldin; D L Kroetz
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

2.  Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume.

Authors:  Chi Young Shim; Sajeevani Kim; Scott Chadderdon; Melinda Wu; Yue Qi; Aris Xie; Nabil J Alkayed; Brian P Davidson; Jonathan R Lindner
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-21       Impact factor: 4.310

3.  The arachidonic acid monooxygenase: from biochemical curiosity to physiological/pathophysiological significance.

Authors:  Jorge H Capdevila; John R Falck
Journal:  J Lipid Res       Date:  2018-08-28       Impact factor: 5.922

4.  Effect of Angiotensin II and ACTH on Adrenal Blood Flow in the Male Rat Adrenal Gland In Vivo.

Authors:  Abdul J Shah; Tamas Kriska; Kathryn M Gauthier; John R Falck; William B Campbell
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

5.  Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs.

Authors:  Phillip G Kopf; Kathryn M Gauthier; David X Zhang; John R Falck; William B Campbell
Journal:  Hypertension       Date:  2011-01-03       Impact factor: 10.190

6.  Downregulated Serum 14, 15-Epoxyeicosatrienoic Acid Is Associated With Abdominal Aortic Calcification in Patients With Primary Aldosteronism.

Authors:  Pinming Liu; Shaoling Zhang; Jingwei Gao; Ying Lin; Guangzi Shi; Wanbing He; Rhian M Touyz; Li Yan; Hui Huang
Journal:  Hypertension       Date:  2018-02-12       Impact factor: 10.190

7.  Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.

Authors:  Ding Ai; Yi Fu; Deliang Guo; Hiromasa Tanaka; Nanping Wang; Chaoshu Tang; Bruce D Hammock; John Y-J Shyy; Yi Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-10       Impact factor: 11.205

8.  EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.

Authors:  Martina Decker; Magdalena Adamska; Annette Cronin; Francesca Di Giallonardo; Julia Burgener; Anne Marowsky; John R Falck; Christophe Morisseau; Bruce D Hammock; Artiom Gruzdev; Darryl C Zeldin; Michael Arand
Journal:  J Lipid Res       Date:  2012-07-12       Impact factor: 5.922

9.  Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.

Authors:  Marlina Manhiani; Jeffrey E Quigley; Sarah F Knight; Shiva Tasoobshirazi; TarRhonda Moore; Michael W Brands; Bruce D Hammock; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-24

10.  Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans.

Authors:  Gail K Adler; Gillian R Murray; Adina F Turcu; Hui Nian; Chang Yu; Carmen C Solorzano; Robert Manning; Dungeng Peng; James M Luther
Journal:  Hypertension       Date:  2020-03-16       Impact factor: 10.190
View more
  1 in total

1.  Salt-Sensitive Hypertension in GR+/- Rats Is Accompanied with Dysregulation in Adrenal Soluble Epoxide Hydrolase and Polyunsaturated Fatty Acid Pathways.

Authors:  Paul-Emmanuel Vanderriele; Qing Wang; Anne-Marie Mérillat; Frédérique Ino; Gilles Aeschlimann; Xavier Ehret; David Ancin Del Olmo; Verónica Ponce de León; Ute I Scholl; Denise V Winter; Alex Odermatt; Edith Hummler; Sophia N Verouti
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.